These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 9672995

  • 1. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury.
    Kühne SA, Neidhart M, Everson MP, Häntzschel H, Fine PR, Gay S, Häuselmann HJ, Gay RE.
    Rheumatol Int; 1998; 18(1):21-5. PubMed ID: 9672995
    [Abstract] [Full Text] [Related]

  • 2. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C, Neidhart M, Gerber T, Hauser N, Michel BA, Häuselmann HJ.
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [Abstract] [Full Text] [Related]

  • 3. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Häuselmann HJ.
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [Abstract] [Full Text] [Related]

  • 4. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
    Skiöldebrand E, Lorenzo P, Zunino L, Rucklidge GJ, Sandgren B, Carlsten J, Ekman S.
    Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy.
    Misumi K, Vilim V, Carter SD, Ichihashi K, Oka T, Sakamoto H.
    Am J Vet Res; 2002 Apr; 63(4):598-603. PubMed ID: 11939326
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M, Jabłońska B.
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
    Clark AG, Jordan JM, Vilim V, Renner JB, Dragomir AD, Luta G, Kraus VB.
    Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
    [Abstract] [Full Text] [Related]

  • 11. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum.
    Yamanokuchi K, Tagami M, Nishimatsu E, Shimizu Y, Hirose Y, Komatsu K, Misumi K.
    Equine Vet J; 2009 Jan; 41(1):41-6. PubMed ID: 19301580
    [Abstract] [Full Text] [Related]

  • 12. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V, Lenz ME, Vytasek R, Masuda K, Pavelka K, Kuettner KE, Thonar EJ.
    Arch Biochem Biophys; 1997 May 01; 341(1):8-16. PubMed ID: 9143347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.
    Addison S, Coleman RE, Feng S, McDaniel G, Kraus VB.
    Arthritis Rheum; 2009 Nov 01; 60(11):3366-73. PubMed ID: 19877068
    [Abstract] [Full Text] [Related]

  • 15. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
    Fernandes FA, Pucinelli ML, da Silva NP, Feldman D.
    Scand J Rheumatol; 2007 Nov 01; 36(3):211-5. PubMed ID: 17657676
    [Abstract] [Full Text] [Related]

  • 16. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M, Jabłońska B.
    Clin Rheumatol; 2005 Jun 01; 24(3):278-84. PubMed ID: 15940561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
    Senolt L, Braun M, Olejárová M, Forejtová S, Gatterová J, Pavelka K.
    Ann Rheum Dis; 2005 Jun 01; 64(6):886-90. PubMed ID: 15897309
    [Abstract] [Full Text] [Related]

  • 19. Chip-based cartilage oligomeric matrix protein detection in serum and synovial fluid for osteoarthritis diagnosis.
    Song SY, Han YD, Hong SY, Kim K, Yang SS, Min BH, Yoon HC.
    Anal Biochem; 2012 Jan 15; 420(2):139-46. PubMed ID: 21982862
    [Abstract] [Full Text] [Related]

  • 20. Serum cartilage oligomeric matrix protein (COMP) expression in individuals who sustained a youth sport-related intra-articular knee injury 3-10 years previously and uninjured matched controls.
    Laudon J, Whittaker JL, Ren G, Jaremko JL, Emery CA, Krawetz RJ.
    Osteoarthritis Cartilage; 2019 Feb 15; 27(2):286-293. PubMed ID: 30317002
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.